Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 2 Billions/5ml		Suspension	595,322 L.L
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 2 Billions		Capsule	831,839 L.L
J01FA10	ERADECIN	G	Azithromycin - 250mg	250mg	Capsule	354,774 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 80mg	80mg	Tablet	2,023,827 L.L
C09DA09	EDARBYCLOR	B	Azilsartan medoxomil - 40mg, Chlortalidone - 25mg		Tablet, film coated	1,846,440 L.L
C09DA09	EDARBYCLOR	B	Azilsartan medoxomil - 40mg, Chlortalidone - 12.5mg		Tablet, film coated	1,846,440 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 40mg	40mg	Tablet	1,846,440 L.L
C10AA05	EMITOR	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,060,292 L.L
C10AA05	EMITOR	G	Atorvastatin - 20mg	20mg	Tablet, film coated	822,432 L.L
B01AF02	ELIQUIS	B	Apixaban - 5mg	5mg	Tablet, film coated	4,183,603 L.L
B01AF02	ELAPIX 5	G	Apixaban - 5mg	5mg	Tablet, film coated	1,970,969 L.L
B01AF02	ELIQUIS	B	Apixaban - 2.5mg	2.5mg	Tablet, film coated	4,183,603 L.L
B01AF02	ELAPIX 2.5	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	1,970,969 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
J02AX06	ECALTA	B	Anidulafungin - 100mg	100mg	Injectable concentrated powder for solution	16,977,343 L.L
C09DB01	EXFORGE	B	Amlodipine - 5mg, Valsartan - 160mg		Tablet, film coated	1,333,092 L.L
C09DB01	EXFORGE	B	Amlodipine - 10mg, Valsartan - 160mg		Tablet, film coated	1,333,092 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 8mg/0.07ml	8mg/0.07ml	Injectable solution	78,332,387 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
N02BE51	EXTRA STRENGTH HEADACHE RELIEF	G	Acetaminophen - 250mg, Acetylsalicylic acid - 250mg, Caffeine - 65mg		Tablet	353,431 L.L

...